⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL372547 | 0.98 | — | — | |
| Hydrochloric Acid SCHEMBL741807 | 0.95 | ALOX15 (0.42) | — | |
| Hydrochloric Acid SCHEMBL20447769 | 0.95 | ALOX15 (0.42) | — | |
| SCHEMBL571438 | 0.89 | SMN1; SMN2 (0.44) | — | |
| SCHEMBL2507803 | 0.89 | ALOX15 (0.41) | — | |
| SCHEMBL16111684 | 0.88 | ALOX15 (0.37) | — | |
| SCHEMBL1812214 | 0.87 | ALOX15 (0.39) | — | |
| Hydrochloric Acid SCHEMBL1279280 | 0.87 | SMN1; SMN2 (0.42) | — | |
| SCHEMBL1837607 | 0.87 | ALOX15 (0.39) | — | |
| Hydrochloric Acid SCHEMBL1279085 | 0.87 | ALOX15 (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3941459-B1 | QUINOLINE AND QUINAZOLINE COMPOUNDS AND METHODS OF USE THEREOF | STINGRAY THERAPEUTICS INC (US) | 2026-05-06 | — | — | EP | disclosed |
| US-11407729-B2 | Quinoline and quinazoline compounds and methods of use thereof | Stingray Therapeutics, Inc. (US) | 2022-08-09 | — | — | US | disclosed |
| EP-3941459-A1 | QUINOLINE AND QUINAZOLINE COMPOUNDS AND METHODS OF USE THEREOF | Stingray Therapeutics, Inc. (US) | 2022-01-26 | — | — | EP | disclosed |
| US-20200299258-A1 | QUINOLINE AND QUINAZOLINE COMPOUNDS AND METHODS OF USE THEREOF | STINGRAY THERAPEUTICS INC (US) | 2020-09-24 | — | — | US | disclosed |
| WO-2020190912-A1 | QUINOLINE AND QUINAZOLINE COMPOUNDS AND METHODS OF USE THEREOF | Stingray Therapeutics, Inc. (US) | 2020-09-24 | — | — | WO | disclosed |